Symbols

NVIV(Delisted)

Invivo Therapeutics·NASDAQ

--(--)

NVIV fundamentals

NVIV Q4 undefined Earnings

Invivo Therapeutics (NVIV) released its earnings on Mar 12, 2018: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), met estimates.

Revenue / YoY

EPS / YoY

Report date

Mar 12, 2018

Earnings

EPS

Revenue

Revenue & Expenses

Key Indicators

Invivo Therapeutics (NVIV) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Invivo Therapeutics (NVIV)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Invivo Therapeutics (NVIV)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Invivo Therapeutics (NVIV)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown

Revenue Breakdown

Where does Invivo Therapeutics (NVIV) generate its revenue? Explore its key revenue streams and top earning regions.

By Business

Data source:

By Region

Data source:

Dividend

Track Invivo Therapeutics (NVIV) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History

Payout Ratio

Dividend Yield

You can ask Aime

No Data